CHD7 and central nervous system cancer: Meanwhile, miR-22 transferred from TAMs to glioma stem cells was able to promote mesenchymal phenotypes and induce radiotherapy resistance by targeting the chromodomain helicase DNA-binding protein 7 (CHD7), a chromodomain enzyme that maintains the proneural phenotype in glioblastoma [26].